Synlogic, Inc.
corporate_fare Company Profile
Synlogic, Inc. (OTC:SYBX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for SYBX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-11, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for SYBX spans 10-Q, 425, SCHEDULE 13D/A, 8-K.
Recent high-impact activity:
- Synlogic Q3 10-Q: $11.6M Cash, Material Weakness Persists Ahead of Caldera Merger
- Caldera Reports Positive CLD-423 Phase 1a Data, Adds IL-17 x TL1A License Ahead of Synlogic Merger
- Synlogic Q2 2026: Cash Runway Through 2027, Merger with Caldera, and Warrant Repricing
- NEA 14 Backs Synlogic-Caldera Merger and Secures Favorable Warrant Terms
- A 28.3% shareholder bloc locks in support for the Synlogic–Caldera merger, removing a key obstacle to closing.
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,854 shares in SYBX as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for SYBX, detected from its recent SEC filings · based on capital-structure filings through 2026-08-14.
Warrant Repricing · Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →